konjac mannan [carb, phsu]
glucomannan [carb, phsu]
glycemia [carb]
coronary heart disease [dsyn]
Type 2 Diabetes [dsyn]
randomized [resa]
Controlled [ftcn]
Metabolic [ftcn]
Trial [resa]
Objective [inpr]
konjac mannan [carb, phsu]
Fiber [food]
Metabolic Control [moft]
Measured [qlco]
glycemia [carb]
Lipidaemia [dsyn]
Blood Pressure [orgf]
High Risk [qlco]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
Research Design [resa]
Methods [inpr]
hypertensive [fndg]
Type 2 [clas]
diabetic [fndg]
Patients [podg]
treated [topp]
Diet, Low-Fat [topp]
Drug Therapy [topp]
baseline [bodm]
Assigned [ftcn]
Take [hlca]
konjac mannan [carb, phsu]
Fiber [food]
enriched [food]
Test [lbpr]
biscuits [food]
kJ [qnco]
kcal [qnco]
glucomannan [carb, phsu]
matched [resa]
placebo [topp]
Wheat Bran [food]
Fiber [food]
biscuits [food]
treatment [ftcn]
Phases [tmco]
Separated [fndg]
Washout Period [tmco]
Diet [food]
Controlled [ftcn]
national [inpr]
Cholesterol [bacs, strd]
Education [edac]
Program [cnce]
STEP 2 [phsu]
Guidelines [inpr]
Medications [phsu]
Maintained [ftcn]
Efficacy [qlco]
Measure [qnco]
included [ftcn]
Fructosamine [carb]
Lipid [lipd]
Profile [lbpr]
Apolipoproteins [aapp, bacs]
Blood Pressure [orgf]
Body Weight [orga]
nutritional analysis [lbpr]
Compared [acty]
placebo [topp]
Reduced [qlco]
Metabolic Control [moft]
Primary [qlco]
End Point [qlco]
Fructosamine [carb]
P NOS [aapp, imft]
Adjusted [ftcn]
Alpha [inpr]
HDL/cholesterol ratio [lbpr]
P NOS [aapp, imft]
Adjusted [ftcn]
Alpha [inpr]
Systolic blood pressure [clna]
6 9 [fndg]
P NOS [aapp, imft]
Adjusted [ftcn]
Alpha [inpr]
secondary [neop]
End Point [qlco]
Including [ftcn]
Body Weight [orga]
Cholesterol, HDL [bacs, lipd]
Triglycerides [bacs, lipd]
Apolipoprotein A-1 [aapp, bacs]
Ratio [qnco]
Glucose [bacs, carb, phsu]
Insulin [aapp, horm, phsu]
Diastolic blood pressure [clna]
Not significant [fndg]
Adjustment [inbe]
Procedure [diap, topp]
Conclusions [idcn]
konjac mannan [carb, phsu]
Fiber [food]
Added [ftcn]
Conventional Treatment [topp]
glycemia [carb]
blood lipid [lipd]
Profile [lbpr]
Systolic blood pressure [clna]
High Risk [qlco]
diabetic [fndg]
Possibly [qlco]
Improving [qlco]
Effectiveness [qlco]
Conventional Treatment [topp]
Type 2 Diabetes [dsyn]
